| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923430 Methods for producing modified glycoproteins |
| 04/12/2011 | US7923251 Method and apparatus for avalanche-mediated transfer of agents into cells |
| 04/12/2011 | US7923250 Transfection with nucleic acid; insertion |
| 04/12/2011 | US7923243 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders |
| 04/12/2011 | US7923236 Fungal enzymes |
| 04/12/2011 | US7923235 CIP1 polypeptides and their uses |
| 04/12/2011 | US7923233 Perhydrolase providing improved peracid stability |
| 04/12/2011 | US7923223 nucleotide sequence encoding a polypeptide Delta 9 desaturase enzyme which has the ability to convert palmitic acid or stearic acid into palmitoleic acid or oleic acid respectively |
| 04/12/2011 | US7923222 Methods of using isolated glucose isomerase |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923217 Specificity in the determination of antithrombin |
| 04/12/2011 | US7923212 Antibodies to cytokine receptor zalpha11 |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | US7923207 Apparatus and system having dry gene silencing pools |
| 04/12/2011 | US7923206 Method of determining a cellular response to a biological agent |
| 04/12/2011 | US7923205 Method for protecting personal information |
| 04/12/2011 | US7923204 Forward mutation assay based on 5-fluorouracil resistance |
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7922917 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 04/12/2011 | US7922483 Method of using a polynucleotide encoding 2.5-diketo-D-gluconic acid reductase |
| 04/12/2011 | CA2626498C Recombinant chimeric virus |
| 04/12/2011 | CA2543846C Hcv replicons containing ns5b from genotype 2b |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2428864C Method and device for collecting and stabilizing a biological sample |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2385245C Thermostable xylanases |
| 04/12/2011 | CA2381037C Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2354054C Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 04/12/2011 | CA2339346C Selection method using a galactose metabolising enzyme |
| 04/12/2011 | CA2326719C Use of triplex structure dna sequences for transferring nucleotide sequences |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA2228769C Method of purifying, stabilising or isolating nucleic acids contained in biological matter |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/12/2011 | CA1341612C Human tissue plasminogen activator variants and processes |
| 04/12/2011 | CA1341611C Interleukin-1 receptors |
| 04/07/2011 | WO2011041796A1 Down-regulation of acc synthase for improved plant performance |
| 04/07/2011 | WO2011041784A1 Methods for diagnosing and treating cancer |
| 04/07/2011 | WO2011041725A2 Schizophrenia treatment response biomarkers |
| 04/07/2011 | WO2011041584A2 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 04/07/2011 | WO2011041582A2 Methods for modulation of autophagy through the modulation of autophagy-inhibiting gene products |
| 04/07/2011 | WO2011041502A1 Aav vectors expressing sec1o for treating kidney damage |
| 04/07/2011 | WO2011041499A2 Isolated rice lp2 promoter and uses thereof |
| 04/07/2011 | WO2011041415A1 Fermentive production of isobutanol using highly effective ketol-acid reductoisomerase enzymes |
| 04/07/2011 | WO2011041411A2 Method for detecting single nucleotide polymorphisms |
| 04/07/2011 | WO2011041402A1 Improved flux to acetolactate-derived products in lactic acid bacteria |
| 04/07/2011 | WO2011041397A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/07/2011 | WO2011041350A2 Xenotropic mulv-related virus (xmrv) compositions and methods of use |
| 04/07/2011 | WO2011041327A1 Light controlled protein dimerization in cells |
| 04/07/2011 | WO2011041093A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | WO2011041011A2 Carbonic anhydrase polypeptides and uses thereof |
| 04/07/2011 | WO2011040971A2 Generation of modified polymerases for improved accuracy in single molecule sequencing |
| 04/07/2011 | WO2011040885A1 A clinical method for genotyping large genes for mutations that potentially cause disease |
| 04/07/2011 | WO2011040880A1 Control of pests in plants |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011040738A2 Intracellular viral vector delivery method employing iron ion/viral vector composite |
| 04/07/2011 | WO2011040612A1 Fluorescent molecule and method for detecting target nucleic acid |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040532A1 Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therein |
| 04/07/2011 | WO2011040527A1 TRANSGENIC BIRD CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, VIRUS, AND VACCINE |
| 04/07/2011 | WO2011040526A1 VIRUS CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, AND METHOD FOR PRODUCTION OF VACCINE |
| 04/07/2011 | WO2011040525A1 Colon cancer marker and method for testing for colon cancer |
| 04/07/2011 | WO2011040503A1 Method for recovery of sensitivity to anti-cancer agents in cancer cell that acquires resistance to anti-cancer agents |
| 04/07/2011 | WO2011040475A1 Method for screening for salty taste control substance |
| 04/07/2011 | WO2011040469A1 Novel pacemaker cell |
| 04/07/2011 | WO2011040429A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | WO2011040421A1 Screening method |
| 04/07/2011 | WO2011040417A1 Inositol-1,4,5-trisphosphate receptor binding protein, and transgenic non-human mammal containing same |
| 04/07/2011 | WO2011040285A1 Dna construct, and process for production of recombinant cho cell using same |
| 04/07/2011 | WO2011040133A1 Human serum amyloid-a3 antibody and use thereof |
| 04/07/2011 | WO2011039729A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
| 04/07/2011 | WO2011039507A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | WO2011039137A1 Lactobacillus and streptococcus promoters and uses thereof |
| 04/07/2011 | WO2011038700A1 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011038473A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines |
| 04/07/2011 | WO2011020120A3 Multi-transgenic pigs for diabetes treatment |
| 04/07/2011 | WO2011018227A3 Peptide libraries |
| 04/07/2011 | WO2011011678A3 Genetically modified rat models for cytokine-cytokine signaling pathways |
| 04/07/2011 | WO2011009182A3 Isolated nucleic acid molecule, genetic construct, vector, transgenic cell, method for producing a transgenic cell and plant, isolated and purified polypeptide, biodegradable pesticide composition, pest control method, method for producing transgenic strains resistant to insect pests |
| 04/07/2011 | WO2011008803A3 Novel δ9-elongase for production of polyunsaturated fatty acid-enriched oils |
| 04/07/2011 | WO2011002077A8 TNF-α GENE THERAPY AGENT CONTAINED IN POLYMERIC MICELLE |
| 04/07/2011 | WO2010132609A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/07/2011 | WO2010131916A3 Sirna conjugate and preparation method thereof |
| 04/07/2011 | WO2010129940A3 Archael laccases and multicopper oxidases (mcos) and their uses thereof |
| 04/07/2011 | WO2010118016A3 Digital quantification of dna methylation |
| 04/07/2011 | WO2010117817A3 Methods for generating target specific probes for solution based capture |
| 04/07/2011 | WO2010108108A3 Polyamine derivatives |
| 04/07/2011 | WO2010099301A3 Piggybac transposon variants and methods of use |
| 04/07/2011 | WO2010093906A3 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 04/07/2011 | WO2010091296A3 Emx2 in cancer diagnosis and prognosis |
| 04/07/2011 | WO2010091049A3 Diagnosis and treatment of cancer |